Global Parkinson’s Disease Therapeutics Market Growth 2018-2023

October 2018 | 162 pages | ID: G4B2139E2A6EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors. 
Over the next five years, LPI(LP Information) projects that Parkinson’s Disease Therapeutics will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Parkinson’s Disease Therapeutics market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Therapeutics market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Oral
• Transdermal
• Subcutaneous
• Intestinal Infusion

Segmentation by application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Abbvie, Inc.
• Biogen, Inc.
• Boehringer Ingelheim GmbH
• F. Hoffman-La Roche
• GlaxoSmithKline Plc.
• H. Lundbeck A/S
• Impax Labs, Inc.
• Newron Pharmaceuticals SpA
• Novartis AG
• Orion Corporation
• Teva Pharmaceutical Industries Ltd.
• UCB S.A.

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Parkinson’s Disease Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Parkinson’s Disease Therapeutics market by identifying its various subsegments.
• Focuses on the key global Parkinson’s Disease Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Parkinson’s Disease Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Parkinson’s Disease Therapeutics submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parkinson’s Disease Therapeutics Consumption 2013-2023
  2.1.2 Parkinson’s Disease Therapeutics Consumption CAGR by Region
2.2 Parkinson’s Disease Therapeutics Segment by Type
  2.2.1 Oral
  2.2.2 Transdermal
  2.2.3 Subcutaneous
  2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Therapeutics Consumption by Type
  2.3.1 Global Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
  2.3.2 Global Parkinson’s Disease Therapeutics Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Parkinson’s Disease Therapeutics Sale Price by Type (2013-2018)
2.4 Parkinson’s Disease Therapeutics Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Parkinson’s Disease Therapeutics Consumption by Application
  2.5.1 Global Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
  2.5.2 Global Parkinson’s Disease Therapeutics Value and Market Share by Application (2013-2018)
  2.5.3 Global Parkinson’s Disease Therapeutics Sale Price by Application (2013-2018)

3 GLOBAL PARKINSON’S DISEASE THERAPEUTICS BY PLAYERS

3.1 Global Parkinson’s Disease Therapeutics Sales Market Share by Players
  3.1.1 Global Parkinson’s Disease Therapeutics Sales by Players (2016-2018)
  3.1.2 Global Parkinson’s Disease Therapeutics Sales Market Share by Players (2016-2018)
3.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players
  3.2.1 Global Parkinson’s Disease Therapeutics Revenue by Players (2016-2018)
  3.2.2 Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2016-2018)
3.3 Global Parkinson’s Disease Therapeutics Sale Price by Players
3.4 Global Parkinson’s Disease Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Parkinson’s Disease Therapeutics Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PARKINSON’S DISEASE THERAPEUTICS BY REGIONS

4.1 Parkinson’s Disease Therapeutics by Regions
  4.1.1 Global Parkinson’s Disease Therapeutics Consumption by Regions
  4.1.2 Global Parkinson’s Disease Therapeutics Value by Regions
4.2 Americas Parkinson’s Disease Therapeutics Consumption Growth
4.3 APAC Parkinson’s Disease Therapeutics Consumption Growth
4.4 Europe Parkinson’s Disease Therapeutics Consumption Growth
4.5 Middle East & Africa Parkinson’s Disease Therapeutics Consumption Growth

5 AMERICAS

5.1 Americas Parkinson’s Disease Therapeutics Consumption by Countries
  5.1.1 Americas Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018)
  5.1.2 Americas Parkinson’s Disease Therapeutics Value by Countries (2013-2018)
5.2 Americas Parkinson’s Disease Therapeutics Consumption by Type
5.3 Americas Parkinson’s Disease Therapeutics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parkinson’s Disease Therapeutics Consumption by Countries
  6.1.1 APAC Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018)
  6.1.2 APAC Parkinson’s Disease Therapeutics Value by Countries (2013-2018)
6.2 APAC Parkinson’s Disease Therapeutics Consumption by Type
6.3 APAC Parkinson’s Disease Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Parkinson’s Disease Therapeutics by Countries
  7.1.1 Europe Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018)
  7.1.2 Europe Parkinson’s Disease Therapeutics Value by Countries (2013-2018)
7.2 Europe Parkinson’s Disease Therapeutics Consumption by Type
7.3 Europe Parkinson’s Disease Therapeutics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parkinson’s Disease Therapeutics by Countries
  8.1.1 Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Parkinson’s Disease Therapeutics Value by Countries (2013-2018)
8.2 Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Type
8.3 Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Parkinson’s Disease Therapeutics Distributors
10.3 Parkinson’s Disease Therapeutics Customer

11 GLOBAL PARKINSON’S DISEASE THERAPEUTICS MARKET FORECAST

11.1 Global Parkinson’s Disease Therapeutics Consumption Forecast (2018-2023)
11.2 Global Parkinson’s Disease Therapeutics Forecast by Regions
  11.2.1 Global Parkinson’s Disease Therapeutics Forecast by Regions (2018-2023)
  11.2.2 Global Parkinson’s Disease Therapeutics Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Parkinson’s Disease Therapeutics Forecast by Type
11.8 Global Parkinson’s Disease Therapeutics Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Abbvie, Inc.
  12.1.1 Company Details
  12.1.2 Parkinson’s Disease Therapeutics Product Offered
  12.1.3 Abbvie, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Abbvie, Inc. News
12.2 Biogen, Inc.
  12.2.1 Company Details
  12.2.2 Parkinson’s Disease Therapeutics Product Offered
  12.2.3 Biogen, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Biogen, Inc. News
12.3 Boehringer Ingelheim GmbH
  12.3.1 Company Details
  12.3.2 Parkinson’s Disease Therapeutics Product Offered
  12.3.3 Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Boehringer Ingelheim GmbH News
12.4 F. Hoffman-La Roche
  12.4.1 Company Details
  12.4.2 Parkinson’s Disease Therapeutics Product Offered
  12.4.3 F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 F. Hoffman-La Roche News
12.5 GlaxoSmithKline Plc.
  12.5.1 Company Details
  12.5.2 Parkinson’s Disease Therapeutics Product Offered
  12.5.3 GlaxoSmithKline Plc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 GlaxoSmithKline Plc. News
12.6 H. Lundbeck A/S
  12.6.1 Company Details
  12.6.2 Parkinson’s Disease Therapeutics Product Offered
  12.6.3 H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 H. Lundbeck A/S News
12.7 Impax Labs, Inc.
  12.7.1 Company Details
  12.7.2 Parkinson’s Disease Therapeutics Product Offered
  12.7.3 Impax Labs, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 Impax Labs, Inc. News
12.8 Newron Pharmaceuticals SpA
  12.8.1 Company Details
  12.8.2 Parkinson’s Disease Therapeutics Product Offered
  12.8.3 Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Newron Pharmaceuticals SpA News
12.9 Novartis AG
  12.9.1 Company Details
  12.9.2 Parkinson’s Disease Therapeutics Product Offered
  12.9.3 Novartis AG Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Novartis AG News
12.10 Orion Corporation
  12.10.1 Company Details
  12.10.2 Parkinson’s Disease Therapeutics Product Offered
  12.10.3 Orion Corporation Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Orion Corporation News
12.11 Teva Pharmaceutical Industries Ltd.
12.12 UCB S.A.

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson’s Disease Therapeutics
Table Product Specifications of Parkinson’s Disease Therapeutics
Figure Parkinson’s Disease Therapeutics Report Years Considered
Figure Market Research Methodology
Figure Global Parkinson’s Disease Therapeutics Consumption Growth Rate 2013-2023 (K Units)
Figure Global Parkinson’s Disease Therapeutics Value Growth Rate 2013-2023 ($ Millions)
Table Parkinson’s Disease Therapeutics Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Transdermal
Table Major Players of Transdermal
Figure Product Picture of Subcutaneous
Table Major Players of Subcutaneous
Figure Product Picture of Intestinal Infusion
Table Major Players of Intestinal Infusion
Table Global Consumption Sales by Type (2013-2018)
Table Global Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Global Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Table Global Parkinson’s Disease Therapeutics Revenue by Type (2013-2018) ($ million)
Table Global Parkinson’s Disease Therapeutics Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Parkinson’s Disease Therapeutics Value Market Share by Type (2013-2018)
Table Global Parkinson’s Disease Therapeutics Sale Price by Type (2013-2018)
Figure Parkinson’s Disease Therapeutics Consumed in Hospitals
Figure Global Parkinson’s Disease Therapeutics Market: Hospitals (2013-2018) (K Units)
Figure Global Parkinson’s Disease Therapeutics Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Parkinson’s Disease Therapeutics Consumed in Clinics
Figure Global Parkinson’s Disease Therapeutics Market: Clinics (2013-2018) (K Units)
Figure Global Parkinson’s Disease Therapeutics Market: Clinics (2013-2018) ($ Millions)
Figure Global Clinics YoY Growth ($ Millions)
Figure Parkinson’s Disease Therapeutics Consumed in Others
Figure Global Parkinson’s Disease Therapeutics Market: Others (2013-2018) (K Units)
Figure Global Parkinson’s Disease Therapeutics Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Global Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Table Global Parkinson’s Disease Therapeutics Value by Application (2013-2018)
Table Global Parkinson’s Disease Therapeutics Value Market Share by Application (2013-2018)
Figure Global Parkinson’s Disease Therapeutics Value Market Share by Application (2013-2018)
Table Global Parkinson’s Disease Therapeutics Sale Price by Application (2013-2018)
Table Global Parkinson’s Disease Therapeutics Sales by Players (2016-2018) (K Units)
Table Global Parkinson’s Disease Therapeutics Sales Market Share by Players (2016-2018)
Figure Global Parkinson’s Disease Therapeutics Sales Market Share by Players in 2016
Figure Global Parkinson’s Disease Therapeutics Sales Market Share by Players in 2017
Table Global Parkinson’s Disease Therapeutics Revenue by Players (2016-2018) ($ Millions)
Table Global Parkinson’s Disease Therapeutics Revenue Market Share by Players (2016-2018)
Figure Global Parkinson’s Disease Therapeutics Revenue Market Share by Players in 2016
Figure Global Parkinson’s Disease Therapeutics Revenue Market Share by Players in 2017
Table Global Parkinson’s Disease Therapeutics Sale Price by Players (2016-2018)
Figure Global Parkinson’s Disease Therapeutics Sale Price by Players in 2017
Table Global Parkinson’s Disease Therapeutics Manufacturing Base Distribution and Sales Area by Players
Table Players Parkinson’s Disease Therapeutics Products Offered
Table Parkinson’s Disease Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Parkinson’s Disease Therapeutics Consumption by Regions 2013-2018 (K Units)
Table Global Parkinson’s Disease Therapeutics Consumption Market Share by Regions 2013-2018
Figure Global Parkinson’s Disease Therapeutics Consumption Market Share by Regions 2013-2018
Table Global Parkinson’s Disease Therapeutics Value by Regions 2013-2018 ($ Millions)
Table Global Parkinson’s Disease Therapeutics Value Market Share by Regions 2013-2018
Figure Global Parkinson’s Disease Therapeutics Value Market Share by Regions 2013-2018
Figure Americas Parkinson’s Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Americas Parkinson’s Disease Therapeutics Value 2013-2018 ($ Millions)
Figure APAC Parkinson’s Disease Therapeutics Consumption 2013-2018 (K Units)
Figure APAC Parkinson’s Disease Therapeutics Value 2013-2018 ($ Millions)
Figure Europe Parkinson’s Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Europe Parkinson’s Disease Therapeutics Value 2013-2018 ($ Millions)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Consumption 2013-2018 (K Units)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Value 2013-2018 ($ Millions)
Table Americas Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Americas Parkinson’s Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Americas Parkinson’s Disease Therapeutics Consumption Market Share by Countries in 2017
Table Americas Parkinson’s Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Americas Parkinson’s Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Americas Parkinson’s Disease Therapeutics Value Market Share by Countries in 2017
Table Americas Parkinson’s Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Americas Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Americas Parkinson’s Disease Therapeutics Consumption Market Share by Type in 2017
Table Americas Parkinson’s Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Americas Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Americas Parkinson’s Disease Therapeutics Consumption Market Share by Application in 2017
Figure United States Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure United States Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Canada Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Canada Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Mexico Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Mexico Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table APAC Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table APAC Parkinson’s Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure APAC Parkinson’s Disease Therapeutics Consumption Market Share by Countries in 2017
Table APAC Parkinson’s Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table APAC Parkinson’s Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure APAC Parkinson’s Disease Therapeutics Value Market Share by Countries in 2017
Table APAC Parkinson’s Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table APAC Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure APAC Parkinson’s Disease Therapeutics Consumption Market Share by Type in 2017
Table APAC Parkinson’s Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table APAC Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure APAC Parkinson’s Disease Therapeutics Consumption Market Share by Application in 2017
Figure China Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure China Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Japan Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Japan Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Korea Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Korea Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure India Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure India Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Australia Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Australia Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Europe Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Europe Parkinson’s Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Europe Parkinson’s Disease Therapeutics Consumption Market Share by Countries in 2017
Table Europe Parkinson’s Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Europe Parkinson’s Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Europe Parkinson’s Disease Therapeutics Value Market Share by Countries in 2017
Table Europe Parkinson’s Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Europe Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Europe Parkinson’s Disease Therapeutics Consumption Market Share by Type in 2017
Table Europe Parkinson’s Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Europe Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Europe Parkinson’s Disease Therapeutics Consumption Market Share by Application in 2017
Figure Germany Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Germany Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure France Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure France Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure UK Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure UK Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Italy Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Italy Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Russia Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Russia Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Spain Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Spain Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Countries in 2017
Table Middle East & Africa Parkinson’s Disease Therapeutics Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Parkinson’s Disease Therapeutics Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Value Market Share by Countries in 2017
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Type in 2017
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Consumption Market Share by Application in 2017
Figure Egypt Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Egypt Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure South Africa Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure South Africa Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Israel Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Israel Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure Turkey Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure Turkey Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Parkinson’s Disease Therapeutics Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Parkinson’s Disease Therapeutics Value Growth 2013-2018 ($ Millions)
Table Parkinson’s Disease Therapeutics Distributors List
Table Parkinson’s Disease Therapeutics Customer List
Figure Global Parkinson’s Disease Therapeutics Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Parkinson’s Disease Therapeutics Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Therapeutics Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Parkinson’s Disease Therapeutics Consumption Market Forecast by Regions
Table Global Parkinson’s Disease Therapeutics Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Therapeutics Value Market Share Forecast by Regions
Figure Americas Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Americas Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure APAC Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure APAC Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Europe Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Europe Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Middle East & Africa Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure United States Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure United States Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Canada Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Canada Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Mexico Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Mexico Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Brazil Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Brazil Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure China Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure China Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Japan Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Japan Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Korea Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Korea Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Southeast Asia Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Southeast Asia Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure India Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure India Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Australia Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Australia Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Germany Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Germany Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure France Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure France Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure UK Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure UK Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Italy Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Italy Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Russia Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Russia Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Spain Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Spain Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Egypt Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Egypt Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure South Africa Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure South Africa Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Israel Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Israel Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure Turkey Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure Turkey Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Figure GCC Countries Parkinson’s Disease Therapeutics Consumption 2018-2023 (K Units)
Figure GCC Countries Parkinson’s Disease Therapeutics Value 2018-2023 ($ Millions)
Table Global Parkinson’s Disease Therapeutics Consumption Forecast by Type (2018-2023) (K Units)
Table Global Parkinson’s Disease Therapeutics Consumption Market Share Forecast by Type (2018-2023)
Table Global Parkinson’s Disease Therapeutics Value Forecast by Type (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Therapeutics Value Market Share Forecast by Type (2018-2023)
Table Global Parkinson’s Disease Therapeutics Consumption Forecast by Application (2018-2023) (K Units)
Table Global Parkinson’s Disease Therapeutics Consumption Market Share Forecast by Application (2018-2023)
Table Global Parkinson’s Disease Therapeutics Value Forecast by Application (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Therapeutics Value Market Share Forecast by Application (2018-2023)
Table Abbvie, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbvie, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbvie, Inc. Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Biogen, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogen, Inc. Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Boehringer Ingelheim GmbH Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table F. Hoffman-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffman-La Roche Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure F. Hoffman-La Roche Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table GlaxoSmithKline Plc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Plc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Plc. Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table H. Lundbeck A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table H. Lundbeck A/S Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure H. Lundbeck A/S Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Impax Labs, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Labs, Inc. Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Impax Labs, Inc. Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Newron Pharmaceuticals SpA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Newron Pharmaceuticals SpA Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis AG Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Orion Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orion Corporation Parkinson’s Disease Therapeutics Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Orion Corporation Parkinson’s Disease Therapeutics Market Share (2016-2018)
Table Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors